The subsequent experiments supported the “dry” findings by demonstrating that mouse rKL supplementation was sufficient to alleviate pulmonary fibrosis in an ex vivo model and to suppress the activation, migration, and ECM production induced by TGF-β in isolated mouse pulmonary fibroblasts. The gene discussed is TGFB1; the disease is pulmonary fibrosis.